V. REFERENCES 



1. Alison, RU . Morgan, K T , Haseman, J.K ; 

 Boorman, G.A. (1987) Morphology and classifi 

 cation of ovarian neoplasms in F344 rats and 

 (C57BIV6 X C3H)Fi mice. J. Natl. Cancer Inst. 

 78:1229-1243. 



11 Biaglow, J.E ; Jacobson, B.E.; Nygaard, O.F 

 (1977) Metabolic reduction of 4-nitroquinoline- 

 /V-oxide and other radical-producing drugs to 

 oxygen-reactive intermediates. Cancer Res. 

 37:3306-3313. 



2. Analytical Profiles of Drug Substances (1976) 

 Vol 5. Florey, K., Ed. New York: Academic 

 Press, p. 348. 



3. Anttinen, H.; Ahonen, A.; Leinonen, A ; Kalli- 

 oinen, M.; Heikkinen, E.S. (1982) Diagnostic 

 imaging of focal nodular hyperplasia of the liver 

 developing during nitrofurantoin therapy. Acta 

 Med. Scand. 211:227-232. 



4 Armitage, P. (1971) Statistical Methods in 

 Medical Research. New York: John Wiley & 

 Sons, Inc., pp. 362-365. 



5. Aufrere, MB.; Hoener, B.-A., Vore, M. (1978) 

 Reductive metabolism of nitrofurantoin in the 

 rat. DrugMetab. Dispos. 6:403-411. 



6. Bates, T.R., Scqueira, J A , Tembo, A.V 

 (1974) Effect of food on nitrofurantoin absorp- 

 tion Clin. Pharmacol Ther 16:63-68. 



7. Beamer, W.G.; Tennent, B.J (1986) Gonado- 

 tropin uptake in genetic and irradiation models 

 of ovarian tumorigenesis. Biol. Reprod. 34:761- 

 770. 



8. Beamer, W.G.; Hoppe, PC; Whitten, W.K. 

 (1985) Spontaneous malignant granulosa cell tu- 

 mors in ovaries of young SWR mice. Cancer Res. 

 45:5575-5581. 



9. Behar, A.; Rachmilewitz, E.; Rahamimoff, R ; 

 Dcnman, M (1965) Experimental nitrofurantoin 

 polyneuropathy in rats. Arch. Neurol. 13:160- 

 163. 



10 Berenblum, I , Ed (1969) Carcinogenicity 

 Testing: A Report of the Panel on Carcinogenic- 

 ity of the Cancer Research Commission of L ICC, 

 Vol. 2. Geneva: International Union Against 

 Cancer. 



12. Bignami, M.; Morpurgo, G.; Pagliani, R.; 

 Carere, A.; Conti, G.; Di Giuseppe, G (1974) 

 Non-disjunction and crossing-over induced by 

 pharmaceutical drugs in Aspergillus nidulans. 

 Mutat. Res. 26:159 170 



13. Biskind, M.S.; Biskind, G R (1944) Develop- 

 ment of tumors in the rat ovary after transplan- 

 tation into the spleen. Proc. Soc. Exp. Biol. Med. 

 55:176-179. 



14 Boorman, G.A.. Montgomery, C.A , Jr . Eus- 

 tis, S L., Wolfe, M J.; McConnell, E.E.; Hardisty, 

 J F (1985) Quality assurance iti pathology for 

 rodent carcinogenicity studies Milman, H., 

 Weisburger, E., Eds : Handbook of Carcinogen 

 Testing Park Ridge, N'J: Noyes Publications, 

 pp 345-357 



15 Boyd, MR; Stiko. AW; Sasame, HA. 

 (1979a) Metabolic activation of nitrofurantoin- 

 possible implications for carcinogenesis. Bio- 

 chem Pharmacol. 28:601 606. 



16 Boyd, MR, Calignani, G.E.; Sasame, HA.; 

 Mitchell, JR. Stiko, AW (1979b) Acute pul 

 monary injury in rats by nitrofurantoin and 

 modification by vitamin E, dietary fat, and oxy- 

 gen Am Rev. Respir Dis. 120:93-99 



17 Braunlich, H.; Bonow, A . Schroter, S (1978) 

 Age dependence of renal tubular reabsorption of 

 nitrofurantoin Arch Int Pharmacodyn. Ther. 

 232:92-101 



18. Bron, J . Vree, T B ; Damsma, J E ; Hekster, 

 Y.A.; van der Kleijn, E. (1979) Dissolution, bio- 

 availability, and pharmacokinetics of three ni- 

 trofur'intoin preparations in man. Arzneimittel- 

 forschung 29:1614-1620. 



Nitrofurantoin, NTP TR 341 



68 



